The field of Longevity is rapidly emerging as one of the most exciting frontiers in science, biotechnology, and healthcare innovation, with the potential to significantly impact quality of life, healthy aging, and human healthspan.
A recent in-depth article published by Globes highlights four promising Israeli companies operating at the forefront of this growing field. Among them is SIRTlab, a company established based on the groundbreaking research of Prof. Haim Cohen from Bar-Ilan University.
SIRTlab is developing an innovative drug designed to increase the production of the SIRT6 protein, which is being studied for its role in aging processes, metabolism, and age-related health. The company represents a meaningful example of how advanced academic research can evolve into entrepreneurial and translational opportunities with significant scientific, medical, and industrial potential.
Bar-Ilan University is a shareholder in SIRTlab, reflecting the importance of connecting academic excellence with innovation, commercialization, and real-world impact.
Read the full Globes article:
https://www.globes.co.il/news/article.aspx?did=1001540601